Managing newly diagnosed follicular lymphoma: state of the art and future perspectives

Author： Li Zhi-Ming Ghielmini Michele Moccia Alden A

ISSN： 1473-7140

Source： Expert Review of Anticancer Therapy, Vol.13, Iss.3, 2013-03, pp. : 313-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma on Cirrhosis: State of the Art and Future Perspectives

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 69-76

Bentham Science Publishers

Access to resources Recommend Favorite

Neoadjuvant Strategies for Triple Negative Breast Cancer: ‘State-of-the-art’ and Future Perspectives

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 1, 2015-01 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy

By Lavely W.C. Delbeke D. Greer J.P. Morgan D.S. Byrne D.W. Price R.R. Hallahan D.E.

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 307-315

Elsevier

Access to resources Recommend Favorite

Newly diagnosed multiple myeloma

By Weber Donna

Current Treatment Options in Oncology, Vol. 3, Iss. 3, 2002-06 ,pp. : 235-245

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab for the treatment of follicular lymphoma

By Cheah Chan Y Lingaratnam Senthil Seymour John F

Future Oncology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1283-1298

Future Medicine

Access to resources Recommend Favorite